{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T16:35:08Z","timestamp":1718901308676},"reference-count":52,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Context: Little is known about the relationship between GH and cardiovascular risk markers in women without organic hypothalamic\/pituitary disease.<\/jats:p><jats:p>Objective: The objective of the study was to determine whether healthy young overweight and obese women, who would be classified as having GH deficiency (GHD) based on standard criteria used in hypopituitarism (peak GH after stimulation with GHRH and arginine &amp;lt; 5 ng\/ml), have increased cardiovascular risk markers.<\/jats:p><jats:p>Design: This was a cross-sectional study.<\/jats:p><jats:p>Setting: The study was conducted at the General Clinical Research Center.<\/jats:p><jats:p>Study Participants: Forty-five women of reproductive age, mean age 33.1 \u00b1 1.2 yr and mean body mass index (BMI) 30.9 \u00b1 1.0 kg\/m2.<\/jats:p><jats:p>Intervention: There was no intervention.<\/jats:p><jats:p>Main Outcome Measures: Measures included carotid intima-medial thickness, high-sensitivity C-reactive protein (hsCRP), total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein, triglycerides, E-selectin, soluble intercellular adhesion molecule-1, TNF-\u03b1 receptor I, TNF-\u03b1 receptor II, fasting insulin levels, and oral glucose tolerance testing.<\/jats:p><jats:p>Results: Twenty-six percent of overweight or obese subjects and none with BMI less than 25 kg\/m2 met criteria for GHD. Subjects who met GHD criteria had a mean BMI of 37.0 \u00b1 1.7 kg\/m2 (range 28.6\u201343.6 kg\/m2), and their mean waist circumference (110.1 \u00b1 3.5 cm) was higher than in overweight\/obese women with GH sufficiency (P = 0.007). Mean carotid intima-media thickness, hsCRP, soluble intercellular adhesion molecule-1, TNF-\u03b1 receptor I, and TNF-\u03b1 receptor II levels were higher, and HDL lower, in women meeting GHD criteria than in GH sufficiency. Differences in HDL, hsCRP, and TNF-\u03b1 receptor II remained after controlling for age plus BMI, waist circumference, or trunk fat. There were no differences in measures of insulin resistance.<\/jats:p><jats:p>Conclusions: There may be a relative GHD syndrome in overweight and obese women without organic pituitary or hypothalamic disease that confers increased cardiovascular risk, independent of weight.<\/jats:p>","DOI":"10.1210\/jc.2008-0169","type":"journal-article","created":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T00:54:12Z","timestamp":1209516852000},"page":"2507-2514","source":"Crossref","is-referenced-by-count":46,"title":["Growth Hormone Deficiency by Growth Hormone Releasing Hormone-Arginine Testing Criteria Predicts Increased Cardiovascular Risk Markers in Normal Young Overweight and Obese Women"],"prefix":"10.1210","volume":"93","author":[{"given":"Andrea L.","family":"Utz","sequence":"first","affiliation":[{"name":"Neuroendocrine Unit (A.L.U., A.Y., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (A.L.U., A.Y., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Hemphill","sequence":"additional","affiliation":[{"name":"Department of Cardiology (L.H.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen K.","family":"Miller","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (A.L.U., A.Y., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071613362659500_R1","first-page":"1169","article-title":"The effect of hypopituitarism on life expectancy.","volume":"81","author":"Bates","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R2","first-page":"574","article-title":"Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors.","volume":"85","author":"Bulow","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism.","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"key":"2020071613362659500_R4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"2020071613362659500_R5","first-page":"769","article-title":"[Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution?].","volume":"69","author":"Wuster","year":"1991","journal-title":"Klin Wochenschr"},{"key":"2020071613362659500_R6","first-page":"1329","article-title":"Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency.","volume":"84","author":"Borson-Chazot","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R7","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1210\/jcem.82.5.3951","article-title":"Increased arterial intima-media thickness in childhood-onset growth hormone deficiency.","volume":"82","author":"Capaldo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.1999.00671.x","article-title":"Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.","volume":"50","author":"Evans","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613362659500_R9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.14.3.434","article-title":"High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults.","volume":"14","author":"Johansson","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"2020071613362659500_R10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1365-2265.2002.01663.x","article-title":"Intima-media thickness in cariovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors.","volume":"57","author":"Leonsson","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613362659500_R11","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/0140-6736(92)92892-J","article-title":"Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults.","volume":"340","author":"Markussis","year":"1992","journal-title":"Lancet"},{"key":"2020071613362659500_R12","first-page":"453","article-title":"Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.","volume":"84","author":"Pfeifer","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/acta.0.1290195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency.","volume":"129","author":"Rosen","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071613362659500_R14","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1210\/jcem.86.12.8087","article-title":"Inflammatory cardiovascular risk markers in women with hypopituitarism.","volume":"86","author":"Sesmilo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1530\/eje.1.02125","article-title":"Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency.","volume":"154","author":"Bollerslev","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2020071613362659500_R16","first-page":"550","article-title":"Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women.","volume":"82","author":"Burman","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0038-1650594","article-title":"Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.","volume":"76","author":"Johansson","year":"1996","journal-title":"Thromb Haemost"},{"key":"2020071613362659500_R18","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials.","volume":"89","author":"Maison","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann Intern Med"},{"key":"2020071613362659500_R20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2006.02569.x","article-title":"GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50\u201390.","volume":"65","author":"Carmichael","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613362659500_R21","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1210\/jcem.87.5.8509","article-title":"Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.","volume":"87","author":"Biller","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.292.2.210","article-title":"Growth hormone-releasing hormone in HIV-infected men with lipodystrophy.","volume":"292","author":"Koutkia","year":"2004","journal-title":"JAMA"},{"key":"2020071613362659500_R23","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJMcpc049016","article-title":"Laboratory reference values.","volume":"351","author":"Kratz","year":"2004","journal-title":"N Engl J Med"},{"key":"2020071613362659500_R24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.1.01967","article-title":"The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.","volume":"153","author":"Corneli","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2020071613362659500_R25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","article-title":"Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia.","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2020071613362659500_R26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"2020071613362659500_R27","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1210\/jc.2002-021938","article-title":"Reduced longevity in untreated patients with isolated growth hormone deficiency.","volume":"88","author":"Besson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl A","key":"2020071613362659500_R28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1096-6374(99)80005-7","article-title":"High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results","volume":"9","author":"Erfurth","year":"1999","journal-title":"Growth Horm IGF Res"},{"key":"2020071613362659500_R29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/ajcn\/77.3.544","article-title":"Blunted lipolytic response to fasting in abdominally obese women: evidence for involvement of hyposomatotropism.","volume":"77","author":"Buijs","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"2020071613362659500_R30","first-page":"3156","article-title":"Obesity attenuates the growth hormone response to exercise.","volume":"84","author":"Kanaley","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R31","first-page":"83","article-title":"Low concentrations of insulin-like growth factor-I in abdominal obesity.","volume":"17","author":"Marin","year":"1993","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2020071613362659500_R32","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1210\/jc.2004-0894","article-title":"Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk.","volume":"90","author":"Miller","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R33","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1210\/jcem.86.11.8061","article-title":"Altered neuroregulation of GH secretion in viscerally obese premenopausal women.","volume":"86","author":"Pijl","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/jcem-72-1-51","article-title":"Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.","volume":"72","author":"Veldhuis","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/meta.2003.50007","article-title":"Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.","volume":"52","author":"Weltman","year":"2003","journal-title":"Metabolism"},{"key":"2020071613362659500_R36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199901073400103","article-title":"Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.","volume":"340","author":"O\u2019Leary","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071613362659500_R37","first-page":"1557","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"2002"},{"key":"2020071613362659500_R38","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"2020071613362659500_R39","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.288.8.980","article-title":"Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women\u2019s Health Initiative observational study.","volume":"288","author":"Pradhan","year":"2002","journal-title":"JAMA"},{"key":"2020071613362659500_R40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/sj.ijo.0800889","article-title":"Relationships between IGF-1 and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients.","volume":"23","author":"Maccario","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2020071613362659500_R41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/edrv.22.1.0419","article-title":"The somatomedin hypothesis: 2001.","volume":"22","author":"Le Roith","year":"2001","journal-title":"Endocr Rev"},{"key":"2020071613362659500_R42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.physiol.63.1.141","article-title":"Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles.","volume":"63","author":"Butler","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"2020071613362659500_R43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI20660","article-title":"The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity.","volume":"113","author":"Clemmons","year":"2004","journal-title":"J Clin Invest"},{"key":"2020071613362659500_R44","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1172\/JCI117427","article-title":"Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.","volume":"94","author":"Hussain","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071613362659500_R45","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0026-0495(91)90006-I","article-title":"Growth hormone alters lipolysis and hormone-sensitive lipase activity in 3T3\u2013F442A adipocytes.","volume":"40","author":"Dietz","year":"1991","journal-title":"Metabolism"},{"key":"2020071613362659500_R46","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1210\/jc.2007-0068","article-title":"Growth hormone reduces inflammation in postmenopausal women with abdominal obesity: a 12-month, randomized, placebo-controlled trial.","volume":"92","author":"Franco","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R47","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2004-1657","article-title":"Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.","volume":"90","author":"Franco","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R48","first-page":"727","article-title":"Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.","volume":"82","author":"Johannsson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R49","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1210\/jc.2003-031264","article-title":"Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity.","volume":"89","author":"Albert","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613362659500_R50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ghir.2006.10.001","article-title":"The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.","volume":"17","author":"Albert","year":"2007","journal-title":"Growth Horm IGF Res"},{"key":"2020071613362659500_R51","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2265.2006.02490.x","article-title":"Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control.","volume":"64","author":"Ahn","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613362659500_R52","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/7\/2507\/9056762\/jcem2507.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/7\/2507\/9056762\/jcem2507.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T16:05:12Z","timestamp":1708877112000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/7\/2507\/2598480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,1]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-0169","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,1]]}}}